Disease surveillance systems monitor communicable disease occurrence and trends to inform public health response and disease prevention efforts. Kenya's surveillance capacity has expanded but remains limited for comprehensive disease detection and monitoring across all disease categories and geographic areas.
Passive surveillance relies on healthcare providers reporting diagnosed diseases to health authorities. Healthcare facilities report cases of notifiable diseases to district health offices, which report to national level. Passive surveillance depends on provider awareness of reporting requirements, diagnostic capability, and motivation to report.
Case definitions establish standardized criteria for disease diagnosis and reporting. WHO and national case definitions guide surveillance. However, case definitions are sometimes ambiguous or poorly understood by healthcare workers, leading to inconsistent case identification.
Reporting completeness is variable. Some facilities report all cases; others report incompletely or not at all. Lack of reporting requirements enforcement contributes to underreporting. Private sector reporting is particularly incomplete, with many private practitioners not reporting notifiable diseases.
Active surveillance involves periodic contact by surveillance officers with healthcare facilities to systematically identify and report cases. Active surveillance identifies cases that would otherwise be missed in passive systems but is resource-intensive.
Sentinel surveillance involves a network of specific facilities that report all cases of targeted diseases (surveillance subjects), providing early warning of disease activity. Sentinel sites are usually major facilities likely to diagnose many cases. Sentinel surveillance provides earlier detection than passive surveillance but may miss cases at non-sentinel sites.
Laboratory-based surveillance reports laboratory-confirmed cases, improving diagnostic accuracy. However, laboratory capacity and access to testing vary; some cases are not laboratory-confirmed.
Syndromic surveillance monitors symptoms or syndromes (diarrhea, respiratory illness, fever) rather than confirmed diagnoses. This approach allows early detection of potential outbreaks before confirmed diagnosis. However, syndromic surveillance has high sensitivity but lower specificity, requiring follow-up investigation.
Contact tracing for diseases like AIDS, tuberculosis, and sexually transmitted infections involves identifying and testing contacts of known cases. Effectiveness depends on case cooperation, contact willingness to test, and follow-up. Privacy concerns and stigma can limit contact tracing effectiveness.
Outbreak investigation involves systematic inquiry into clusters of cases to identify etiology, risk factors, and transmission. Outbreak investigation requires trained epidemiologists and laboratory support that are sometimes unavailable.
COVID-19 pandemic exposed and stressed surveillance systems. While surveillance identified cases, capacity for containment (isolation, contact tracing, quarantine) was overwhelmed in many areas.
Vaccine-preventable disease surveillance tracks conditions like polio, measles, and diphtheria. These diseases require very low case numbers for confirmation of elimination or eradication. Surveillance for these conditions is sensitive to detect rare cases.
Malaria surveillance monitors case numbers and helps identify areas with high transmission requiring targeted control efforts.
Tuberculosis surveillance tracks new cases and treatment outcomes. TB case reporting is reasonably complete given high diagnosis rates, but some cases are missed.
Data quality in surveillance systems is variable. Delays in case reporting, incomplete information, and duplicate reporting of cases are common problems.
Timeliness of surveillance reporting affects response. Delays between case diagnosis and reporting mean that outbreak response is delayed. Real-time surveillance systems can identify outbreaks within hours; traditional monthly reporting systems identify outbreaks months after onset.
Confidentiality and privacy protections in surveillance systems are important, particularly for stigmatized diseases. Systems must protect patient identity while collecting necessary information. Breaches of confidentiality can discourage case reporting and patient cooperation.
Surveillance data use for decision-making and action varies. Some districts and regions use surveillance data to guide prevention and response efforts; others collect data but do not act on findings.
Epidemiological training for surveillance and outbreak response is limited. Few individuals have formal training in epidemiology, limiting capacity for data analysis and outbreak investigation.
International disease surveillance reporting to WHO and other international bodies provides global disease monitoring. Kenya participates in international surveillance through disease reporting.
Surveillance for non-communicable diseases is limited. Diseases like cancer, cardiovascular disease, and diabetes are not systematically monitored, limiting capacity to assess disease burden and trends.
Surveillance for occupational and environmental diseases is minimal, despite significant burden from occupational injuries, pesticide exposure, and environmental hazards.
See Also
Disease Surveillance Systems Health Information Systems Epidemiology Studies Kenya Public Health Communication Healthcare Policy Evolution Hospital Infrastructure Standards Communicable Disease Control
Sources
- Kenya Ministry of Health Integrated Disease Surveillance and Response Strategy (2013), https://www.health.go.ke/
- WHO Global Disease Surveillance Database (2023), https://www.who.int/data/surveillance/
- Kipchoge, P., et al. (2016). Evaluation of the disease surveillance system in Kenya: A mixed methods approach. Epidemiology and Infection, 144(11). https://doi.org/10.1017/S0950268816000923